AB 2436, as amended, Roger Hernández. Health care coverage: disclosures: drug pricing.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law also provides for the regulation of health insurers by the Department of Insurance. Existing law imposes various requirements on contracts and policies that cover prescription drug benefits.
This bill would require a health care service plan contract or a policy of health insurance that is issued, amended, or renewed on or after January 1, 2017, and that provides coverage for prescription drug benefits to notify the enrollee orbegin delete insuredend deletebegin insert
insured, at the time that a prescription drug is delivered or within 30 days of purchase,end insert of specified information related to the cost ofbegin delete aend deletebegin insert theend insert prescriptionbegin delete drug at the time that the drug is purchased or delivered.end deletebegin insert drug. The bill would require a health care service plan or a health insurer, in contracting with a pharmaceutical manufacturer for the purchase of a prescription drug, to require the manufacturer to disclose to the plan or insurer the cost of the prescription drug in United States dollars in Canada, Germany, and Mexico. The bill would make related legislative findings and declarations.end insert
Because a willful violation of the bill’s requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Vote: majority. Appropriation: no. Fiscal committee: yes. State-mandated local program: yes.
The people of the State of California do enact as follows:
(a) The Legislature finds and declares that the
2escalating cost of prescription drugs is a major concern for
3Californians.
4
(b) It is the intent of the Legislature in enacting this bill to
5provide consumers with information about the cost of prescription
6drugs, including the cost to the health plan or insurer and the cost
7in other countries.
8
(c) It is not the intent of the Legislature in enacting this bill to
9encourage Californians to purchase or otherwise
obtain
10prescription drugs from other countries in violation of federal law.
Section 1367.207 is added to the Health and Safety
13Code, immediately following Section 1367.205begin insert, end insert to read:
begin insert(a)end insertbegin insert end insert A health care service plan contract issued,
15amended, or renewed on or after January 1, 2017, that provides
16coverage for prescription drug benefits shall require the plan to
17notify the enrollee of the following at thebegin delete time of purchase orend delete time
18of deliverybegin insert or within 30 days of purchaseend insert of a prescription drug:
8 19(a)
end delete
20begin insert(1)end insert The enrollee’s share of the cost for the prescription drug,
21including any copayment, coinsurance, or other cost sharing, and
22the accumulation of that cost sharing to the enrollee’s deductible,
23if any, or out-of-pocket maximum.
12 24(b)
end delete
P3 1begin insert(2)end insert The cost of the prescription drug to the plan, after applying
2any discounts, rebates, or other reductions in cost to the plan.
14 3(c)
end delete
4begin insert(3)end insert The cost of the prescription drug in United States dollars in
5the following countries:
16 6(1)
end delete7begin insert(A)end insert Canada.
17 8(2)
end delete9begin insert(B)end insert Germany.
18 10(3)
end delete11begin insert(C)end insert Mexico.
begin insert
12
(b) In contracting with a pharmaceutical manufacturer for the
13purchase of a prescription drug, a health care service plan or its
14contracting pharmacy benefits manager, if any, shall require the
15pharmaceutical manufacturer to disclose to the plan the cost of
16the prescription drug in United States dollars in Canada, Germany,
17and Mexico. If the pharmaceutical manufacturer fails to provide
18that
information, the health care service plan may take that failure
19into account in determining whether to include the prescription
20drug in the plan’s drug formulary or in which tier of the plan’s
21drug formulary to place the prescription drug.
Section 10123.202 is added to the Insurance Code, 24immediately following Section 10123.201, to read:
begin insert(a)end insertbegin insert end insert A policy of health insurance issued, amended,
26or renewed on or after January 1, 2017, that provides coverage for
27prescription drug benefits shall require the insurer to notify the
28insured of the following at thebegin delete time of purchase orend delete time of delivery
29begin insert or within 30 days of purchaseend insert of a prescription drug:
26 30(a)
end delete
31begin insert(1)end insert The insured’s share of the cost for the prescription drug,
32including any copayment, coinsurance, or other cost sharing, and
33the accumulation of that cost sharing to the insured’s deductible,
34if any, or out-of-pocket maximum.
30 35(b)
end delete
36begin insert(2)end insert The cost of the prescription drug to the insurer, after applying
37any discounts, rebates, or other reductions in cost to the insurer.
32 38(c)
end delete
39begin insert(3)end insert The cost of the prescription drug in United States dollars in
40the following countries:
P3 1 P3 1(1)
end delete2begin insert(A)end insert Canada.
2 3(2)
end delete4begin insert(B)end insert Germany.
3 5(3)
end delete6begin insert(C)end insert Mexico.
begin insert
7
(b) In contracting with a pharmaceutical manufacturer for the
8purchase of a prescription drug, a health insurer or its contracting
9pharmacy benefits manager, if any, shall require the
10pharmaceutical manufacturer to disclose to the insurer the cost
11
of the prescription drug in United States dollars in Canada,
12Germany, and Mexico. If the pharmaceutical manufacturer fails
13to provide that information, the health insurer may take that failure
14into account in determining whether to include the prescription
15drug in the insurer’s drug formulary or in which tier of the
16insurer’s drug formulary to place the prescription drug.
No reimbursement is required by this act pursuant to
19Section 6 of Article XIII B of the California Constitution because
20the only costs that may be incurred by a local agency or school
21district will be incurred because this act creates a new crime or
22infraction, eliminates a crime or infraction, or changes the penalty
23for a crime or infraction, within the meaning of Section 17556 of
24the Government Code, or changes the definition of a crime within
25the meaning of Section 6 of Article XIII B of the California
26Constitution.
O
98